June 2, 2010 Inflammatory bowel disease (IBD) is a disease of the gastrointestinal tract, mainly the intestines that may occur in the people who have genetic potential with a contribution of environmental factors. There has been no definitive medical treatment and drugs usually help the symptoms just to relieve.
Local anesthetics are used to locally desensitize the tissues to allow surgical interventions. However, their mechanism of action is based on their potential to inhibit neuronal activity in the area. Since it is proposed that IBD may be a result of imbalance in the autonomic neurons of the colon, local anesthetics have the potential to reduce the inflammation at the site of the colon that are affected by IBD.
A research article to be published on May 28, 2010 in the World Journal of Gastroenterology addresses this question. In a recent experimental study, investigators from Uludag University School of Medicine, Bursa, Turkey investigated the possible therapeutic effects of local anesthetics on IBD. They topically applied levobupivacaine, which is a novel, long lasting local anesthetic with less systemic side effects onto the colonic mucosa of the rats that had had experimentally induced IBD.
The researchers used some scoring systems that evaluated the inflammation at the site of drug application. They compared the local anesthetics to saline solution. They found some improvement in the degree of macroscopic inflammation at the areas where local anesthetics were applied; however, those findings were not supported by microscopic findings. Nevertheless, researchers concluded that local anesthetics might have potential therapeutic effects on IBD based on their findings.
Other social bookmarking and sharing tools:
- Duman U, Yilmazlar A, Ozturk E, Aker S, Sarandol E, Yilmazlar T. Anti-inflammatory efficiency of levobupivacaine in an experimental colitis model. World Journal of Gastroenterology, 2010; 16 (20): 2537 DOI: 10.3748/wjg.v16.i20.2537
Note: If no author is given, the source is cited instead.